StoneX Reveals Diverse, Small-Cap Equity Holdings in Q4 2023 13F

TL;DR

**StoneX's latest 13F shows a highly diversified portfolio of small, speculative positions as of Q4 2023.**

AI Summary

StoneX Group Inc. (SNEX) filed its 13F-HR on February 12, 2024, revealing its equity holdings as of December 31, 2023. The filing shows a diverse portfolio with numerous small positions, including 10,000 shares of ATARA BIOTHERAPEUTICS INC valued at $5, 10,045 shares of EDGIO INC valued at $3, and 10,591 shares of MEDICAL PPTYS TRUST INC valued at $54. This matters to investors because it provides transparency into StoneX's investment strategy, indicating a preference for a broad range of smaller, potentially speculative, holdings rather than concentrated bets on a few large-cap stocks.

Why It Matters

This filing offers a look into StoneX's investment strategy, showing where the firm is allocating capital, which can influence investor perception and potentially impact the stock's valuation.

Risk Assessment

Risk Level: medium — The portfolio's high diversification across many small-cap and micro-cap stocks, some with very low dollar values, suggests a higher risk tolerance, as these companies can be more volatile.

Analyst Insight

Investors should note StoneX's strategy of holding many small, diverse positions, which could indicate a broad market exposure rather than conviction in specific large-cap names. This approach might appeal to investors seeking diversified exposure through StoneX, but also suggests a higher risk profile due to the nature of small-cap investments.

Key Numbers

• 20231231 — Conformed Period of Report (The date the reported holdings are accurate as of, showing the portfolio's status at the end of Q4 2023.)
• 10,000 SH — Shares of ATARA BIOTHERAPEUTICS INC (Represents a specific position size within StoneX's reported holdings.)
• 10,045 SH — Shares of EDGIO INC (Represents a specific position size within StoneX's reported holdings.)
• 10,591 SH — Shares of MEDICAL PPTYS TRUST INC (Represents a specific position size within StoneX's reported holdings.)
• 20240212 — Filed As Of Date (The date the 13F-HR filing was submitted to the SEC, indicating its recency.)

Key Players & Entities

• StoneX Group Inc. (company) — the filer of the 13F-HR
• John Calvano (person) — CCO, StoneX Advisors Inc.
• ATARA BIOTHERAPEUTICS INC (company) — a holding in StoneX's portfolio
• EDGIO INC (company) — a holding in StoneX's portfolio
• MEDICAL PPTYS TRUST INC (company) — a holding in StoneX's portfolio
• $5 (dollar_amount) — value of ATARA BIOTHERAPEUTICS INC holding
• $3 (dollar_amount) — value of EDGIO INC holding
• $54 (dollar_amount) — value of MEDICAL PPTYS TRUST INC holding

Forward-Looking Statements

• StoneX will continue to maintain a highly diversified portfolio with numerous small positions in its next 13F filing. (StoneX Group Inc.) — medium confidence, target: Q1 2024 13F filing (due May 2024)
• The low dollar values of many holdings suggest these are either highly speculative bets or residual positions from prior strategies. (StoneX Group Inc.) — high confidence, target: Ongoing

FAQ

Filing Documents

• primary_doc.html (13F-HR)
• primary_doc.xml (13F-HR) — 3KB
• infotable.html (INFORMATION TABLE)
• infotable.xml (INFORMATION TABLE) — 129KB
• 0000913760-24-000029.txt ( ) — 133KB

From the Filing

SEC FORM 13F-HR The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE OMB APPROVAL OMB Number: 3235-0006 Estimated average burden hours per response: 23.8 Report for the Calendar Year or Quarter Ended: 12-31-2023 Check here if Amendment    Amendment Number: This Amendment (Check only one.):    is a restatement.    adds new holdings entries. Institutional Investment Manager Filing this Report: Name: StoneX Group Inc. Address: 230 Park Ave 10th Floor New York , NY   10169 Form 13F File Number: 028-17573 CRD Number (if applicable): The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: John Calvano Title: CCO, StoneX Advisors Inc. Phone: Signature, Place, and Date of Signing: John Calvano Birmingham ,  AL 02-12-2024 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)    13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)    13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 2 Form 13F Information Table Entry Total: 264 Form 13F Information Table Value Total: 814,824 (round to nearest dollar) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] No. Name Form 13F File No. CRD No. (if applicable) SEC File No. (if applicable) CIK 1 SA Stone Investment Advisors Inc. 028-17766 2 STONEX FINANCIAL INC.

View Full Filing

View this 13F-HR filing on SEC EDGAR